566172-79-0

Basic information

• Product Name: Carbamic acid, (trans-4-aminocyclohexyl)methyl-, 1,1-dimethylethyl ester
• CAS NO: 566172-79-0
• Molecular Formula: C12H24N2O2
• Molecular Weight: 228.335
• Mol File: 566172-79-0.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Carbamic acid, (trans-4-aminocyclohexyl)methyl-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, (trans-4-aminocyclohexyl)methyl-, 1,1-dimethylethyl ester(566172-79-0)
• EPA Substance Registry System: Carbamic acid, (trans-4-aminocyclohexyl)methyl-, 1,1-dimethylethyl ester(566172-79-0)

Safety Data

• Hazardous Substances Data: 566172-79-0(Hazardous Substances Data)

Upstream product

• 15803-59-5 (1r,4r)-N¹-methylcyclohexane-1,4-diamine 
• 177906-48-8 trans-N-Boc-1,4-cyclohexanediamine 
• 2615-25-0 trans-1,4-cyclohexyldiamine 
• 566172-78-9 n-butyl trans-(4-aminocyclohexyl)-carbamate 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 945997-80-8 trans-tert-butyl {4-[(4'-cyano-4-ethoxy-biphenyl-3-ylmethyl)-amino]-cyclohexyl}-methyl-carbamate 
• 945996-91-8 trans-3-{[4-(Boc-methyl-amino)-cyclohexylamino]-methyl}-4-methoxy-benzeneboronic acid 
• 1025061-41-9 trans-3-{[4-(Boc-methyl-amino)-cyclohexylamino]-methyl}-4-fluoro-benzeneboronic acid 
• 945998-86-7 trans-tert-butyl {4-[2-methoxy-5-(2-methyl-pyridin-4-yl)-benzylamino]-cyclohexyl}-methyl-carbamate 
• 945997-05-7 trans-3-{[4-(Boc-methyl-amino)-cyclohexylamino]-methyl}-4-ethoxy-benzeneboronic acid 
• 1025060-99-4 trans-tert-butyl {4-[(4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino]-cyclohexyl}-methyl-carbamate 
• 945999-95-1 trans-tert-butyl {4-[5-(6-amino-pyridin-3-yl)-2-methoxy-benzylamino]-cyclohexyl}-methyl-carbamate 
• 945996-93-0 trans-3-{[[4-(Boc-methyl-amino)-cyclohexyl]-(3-chlorobenzo[b]thiophene-2-carbonyl)-amino]-methyl}-4-methoxy-benzeneboronic acid 
• 945997-08-0 trans-3-{[(4-(Boc-methyl-amino)-cyclohexyl)-(3-chloro-benzo[b]thiophene-2-carbonyl)-amino]-methyl}-4-ethoxy-benzeneboronic acid 
• 945996-95-2 trans-3-{[[4-(Boc-methyl-amino)-cyclohexyl]-(3-chloro-4-fluoro-benzo[b]thiophene-2-carbonyl)-amino]-methyl}-4-methoxy-benzeneboronic acid 
• 1025061-58-8 C₃₅H₄₂ClN₅O₄S 
• 945997-14-8 trans-tert-butyl {4-[(3-chloro-benzo[b]thiophene-2-carbonyl)-(4'-cyano-4-methoxy-biphenyl-5-ylmethyl)-amino]-cyclohexyl}-methyl-carbamate 
• 946000-02-8 trans-methyl 4-(3-{[(3-chloro-4,7-difluoro-benzo[b]thiophene-2-carbonyl)-(4-methylamino-cyclohexyl)-amino]-methyl}-4-methoxy-phenyl)-pyridine-2-carboxylate 
• 945996-98-5 trans-3-{[[4-(Boc-methyl-amino)-cyclohexyl]-(3-chloro-4,7-difluoro-benzo[b]thiophene-2-carbonyl)-amino]-methyl}-4-methoxy-benzeneboronic acid 

Relevant articles and documents

IRAK DEGRADERS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

Smooth receptor ligand

The invention relates to the technical field of biology, particularly to a smooth receptor ligand, and provides a smooth receptor ligand or an isomer prodrug, a solvate and a pharmaceutically acceptable salt thereof, wherein the structural formula of the smooth receptor ligand is A-linker-B, A is an extracellular domain ligand structure, B is a transmembrane domain ligand structure, and Linker isa linear subunit inactive to the smooth receptor. According to the novel double-end small molecule ligand for the smooth receptor, by combining the crystal structure data of the smooth receptor, a linker is introduced into the proper sites of an extracellular domain ligand and a transmembrane domain ligand to obtain brand-new double-end ligand small molecules, so that the interaction between the ligand and the receptor and the biological activity of the ligand are enhanced.

SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION

The present invention makes available methods and reagents for modulating proliferation or differentiation in a cell or tissue comprising contacting the cell with a compound. In certain embodiments, the methods and reagents may be employed to correct or inhibit an aberrant or unwanted growth state, e.g., by antagonizing a normal patched pathway or agonizing smoothened orhedgehog activity.